Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver Transplantation

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters

Lost Small Envelope Protein Expression from Naturally Occurring PreS1 Deletion Mutants of Hepatitis B Virus Is Often Accompanied by Increased HBx and Core Protein Expression as Well as Genome Replication

Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins

SAMD4 family members suppress human hepatitis B virus by directly binding to the Smaug recognition region of viral RNA

Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster

Replication, pathogenicity, and transmission of SARS-CoV-2 in minks

Naturally occurring 5' preS1 deletions markedly enhance replication and infectivity of HBV genotype B and genotype C

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

Preparation and functional evaluation of monoclonal antibodies targeting Hepatitis B Virus Polymerase

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection

A SCID mouse-human lung xenograft model of SARS-CoV-2 infection